LaurenH
-
Posts
795 -
Joined
-
Last visited
-
Days Won
27
Content Type
Downloads
Store
Profiles
Forums
Gallery
Blogs
Events
Posts posted by LaurenH
-
-
Study Announcement: Lung Cancer Caregiver Study
If you are over the age of 18 and a romantic partner and the caregiver of someone who has been diagnosed with lung cancer in the past two years, please consider contributing to this important study on the quality of life of caregivers of lung cancer patients and survivors.
This study consists of completing a brief online survey at 2 different time points over the course of six months (initial time point and 6 months later). Some find the surveys helpful for reflecting on their caregiving experience, and you would be contributing to our understanding of the important but understudied topic of the challenges faced by caregivers.
The survey questions will ask you about your feelings about caregiving, your quality of life, your physical health, and the physical health of the lung cancer survivor for whom you are a caregiver. The survey will take approximately 30 minutes at each of the two time points.
This research is being conducted by Trisha Raque-Bogdan, Ph.D. of the University of Denver and Amanda Ginter, Ph.D., of Towson University.
If you would like to participate in this research, please either go to https://udenver.qualtrics.com/SE/?SID=SV_etkPpCNDT9HwkKN or contact Trisha Raque-Bogdan at trisha.raque-bogdan@du.edu.
Thank you for your consideration!
Trisha Raque-Bogdan, Ph.D.
Assistant Professor, Counseling Psychology
University of DenverAmanda Ginter, Ph.D.
Assistant Professor, Family Studies
Towson UniversityThis study has been approved for posting by LUNGevity Foundation.
-
-
On 1/15/2017 at 2:24 PM, April said:
I joined last June, but this is my first post. I'm 62, dx January 2016. Stage 4 nsclc, adeno, pleural effusion, inoperable 3cm tumor & sub-centimetre nodules in both right & left lungs. No mutations. PDl-1 positive 80%. After the initial pleural effusion was drained right upper the lobe remained collapsed. Treatment was 4 Carbo/Alimta, 2 rounds of radiation & Alimta maintenance X 5. Some Pleural effusion always lingered on scans while the 3 cm & the sub-centimetre responded . In August I was hospitalized for pneumonia & pleural effusion, then immediately after I was diagnosed with pneumotitis. I was off treatment for 4 months., last Aug12. SOB & rapid heart rate started with the pneumonia. SOB improved -EKG was normal in September, but rapid heart rate remained, usually 115 on exertion, 100-105 at rest. Onc explains it's because of the disease my heart is working harder. Climbing stairs in our home always challenging. While on prednisone for pneumotitis SOB returned in mid-November due to a pleural effusion, drained. Then another, drained. Tapered off prednisone, chest tube inserted for pleural effusions Dec 7. . Regular drains now every 2 days. Started Keytruda Dec15. Rapid heart rate remains, has been 135 on exertion. At rest 105-115. SOB Did not improve with chest tube as it was supposed to. Oxygen was recommended due to Change in my O2. Since chest tube was inserted o2 is tracked by visiting home nurse & is down to 90. On exertion lower with rapid heart rate. 2nd Keytruda January 6. I do not feel any side effects from Keytruda. My SOB has just declined. My last CT - right lung was difficult to see due to a pleural effusion, left lung has some spots. My onc was onc was on vacation my last visit & I will see home this week along with pulmonary. However, since my September scan the right lung is not getting much air & is operating at about 10%. I am wondering if anyone has had these problems. At first I was using oxygen for exertion, now I'm using it all the time due to changes to more changes in o2. Can I become oxygen reliant? I only do the stairs once a day Very slowly. Thanks, much appreciated.
Hi, April,
Welcome to LCSC. My name is Lauren and I am the Digital Community Manager for LUNGevity Foundation. I am happy to "show you around" and help you get started with our online community. We encourage all new members to create an Introduction post in the Introduce Yourself board. To create a new thread or conversation, click the orange Start New Topic button at the top right of the page. You can also join existing conversations by scrolling to the bottom and clicking in the Reply to this topic box. The discussion boards are a great place to ask questions and learn from others' personal experiences. I'm glad to see that you've already met Tom. He's one of our administrators and he's been an incredible help to many members in this community! In addition to the discussion boards, we also have member blogs, photo galleries, and an event calendar. We're updating the calendar this week with nationwide lung cancer events, so check back next week! I hope that you make many meaningful connections on LCSC. Please do not hesitate to contact me with questions about how to use this site.
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
LUNGevity Foundation Partners With CancerCare to Launch Lung Cancer HELPLine
Free Service Addresses Emotional, Practical, and Information Needs of Lung Cancer Patients
FOR IMMEDIATE RELEASE
Media Contact:
Amanda Greenfield
amanda.greenfield@kingcompr.com
212-561-7430WASHINGTON, DC (January 19, 2017) – LUNGevity, the nation’s leading lung cancer-focused nonprofit organization, today announced the launch of the LUNGevity Lung Cancer HELPLine, a free phone service through which a team of professional oncology social workers will be available to address the emotional, practical, and information needs of people diagnosed with lung cancer, their families, and caregivers.
This year, more than 240,000 people in the U.S. will be diagnosed with lung cancer, which means that hundreds of thousands of lung cancer patients, family members, and caregivers will be responsible for navigating a disease that is likely unfamiliar to them. The LUNGevity Lung Cancer HELPLine will serve as a vital resource and source of support for all affected by the disease.
LUNGevity has partnered with CancerCare®, the leading national organization providing free, professional support services and information to help people manage the emotional, practical, and financial challenges of cancer. CancerCare’s team of professional oncology social workers are uniquely qualified to address these needs. For nearly 73 years, CancerCare has provided free support services to cancer patients aimed at alleviating distress, helping them to obtain the best possible outcomes from their treatment.
Those seeking assistance can call LUNGevity’s new toll-free HELPLine, 844-360-LUNG (5864), from 9:00am – 5:00pm ET, Monday through Friday to:
Receive immediate access to reliable educational resources and programs
Get personalized information about lung cancer and treatment options
Learn effective ways to cope with cancer including managing emotions such as depression, anxiety, or sadness
Improve communication with their health care team and loved ones
Get referrals to financial assistance resources for needs including pain medication, homecare, childcare, medical supplies, transportation for treatment, and copayment assistance related to chemotherapy and targeted treatment therapies. (Provided to those who meet CancerCare’s eligibility guidelines; subject to funding availability.)
Depression, anxiety, strains on relationships, loss of motivation, and financial burdens are commonly experienced by lung cancer patients and can compromise a patient’s ability to complete treatment. LUNGevity developed the Lung Cancer HELPLine to help patients, their caregivers, and families combat these symptoms by offering direct and personalized support for callers across the nation.
“Providing lung cancer patients, their families, and caregivers with the resources and tools they need to address every phase of this disease is a priority,” said Andrea Ferris, President and Chairman of LUNGevity Foundation. “Our goal in setting up this HELPLine is to add dimension to these efforts and provide an additional resource to individuals affected by lung cancer to ensure that no one has to navigate this disease alone.”
The HELPLine will join a number of other critical resources LUNGevity has created to support the needs of lung cancer patients, their caregivers, and loved ones, including Clinical Trial Finder, LifeLine Support Partners, and the recently launched Lung Cancer Navigator Mobile App. Charitable funding for the HELPLine was generously provided by Bristol-Myers Squibb Company and Genentech. For more information on LUNGevity, please visit www.LUNGevity.org.
Click here to read the full press release.
-
LUNGevity Foundation Issues Request for Applications for 2017 Career Development Awards for Translational Research in Lung Cancer
Application now available online
FOR IMMEDIATE RELEASE
Media Contact:
Austin Courtney
acourtney@susandavis.com
(202) 414-0791Washington, D.C. (January 17, 2017) — LUNGevity has issued a Request for Applications (RFA) for translational research for Career Development Awards that will be granted in 2017. The RFA is available on the LUNGevity website at www.LUNGevity.org/career-development-awards and is also posted on the proposalCENTRAL website at https://proposalcentral.altum.com.
LUNGevity’s Career Development Awards for Translational Research program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas.
Successful applicants may receive $100,000 per year for a possible period of three years and will participate as non-voting members of LUNGevity’s Scientific Advisory Board for the duration of the award.
Applicants must be within the first five years of their faculty appointment. The Career Development Awards are mentored awards, and a mentoring plan is part of the required submission.
Projects that will be funded in 2017 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.
Letters of intent must be submitted by Friday, February 20, 2017.
LUNGevity supports the largest research awards program of any lung cancer-focused organization in the United States. Since 2002, LUNGevity has funded 118 projects at 58 institutions in 23 states.
About Lung Cancer in the U.S.
About 1 in 15 Americans will be diagnosed with lung cancer in their lifetime
More than 224,000 people in the U.S. will be diagnosed with lung cancer this year
About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
Lung cancer takes more lives than the next four deadliest cancers (colorectal, pancreatic, breast, and prostate) combined
Only 18% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it’s caught before it spreads, the chance for 5-year survival improves dramatically
About LUNGevity Foundation
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, please visit www.LUNGevity.org.
Click here to read the full press release online.
-
It has come to our attention that a user claiming to be an oncologist turned alternative and integrative medicine practitioner has sent personal messages with inappropriate content to at least 22 users. This is a direct violation of the Terms of Use of this site. We apologize to the LCSC members who were contacted by this person. Thank you to the LCSC users who reported these actions. The user has been banned and the administrators are working to make sure that person cannot access the site.
If you receive any inappropriate message, please report it to the administrators so that we can take action to block that user and maintain the integrity of this site.
To report a post:
- Click Report Post in the dateline of the post
- You have the option to add a message explaining why you are reporting the post
- Click Submit Report
To report a message:
- Click Report in the dateline of the conversation
- You have the option to add a message explaining why you are reporting the message
- Click Submit
Thank you for helping to keep LCSC a safe and supportive space for our 11,200 members.
-
Edward Garon, MD, of UCLA joins the LUNGevity Foundation Scientific Advisory Board
Dr. Garon brings expertise in clinical trials and other key areas to LUNGevity’s research program
FOR IMMEDIATE RELEASE
Media Contact:
Austin Courtney
acourtney@susandavis.com
(202) 414-0791WASHINGTON, DC (January 13, 2017) – LUNGevity Foundation, the nation’s preeminent lung cancer research foundation, today announced that Edward Garon, MD, has joined LUNGevity’s Scientific Advisory Board, a group of 19 world-renowned scientists and researchers who guide LUNGevity’s scientific strategy and research program. The Scientific Advisory Board is integral to the Foundation, overseeing the scientific approach and ensuring that grants are awarded to the researchers whose proposals demonstrate the greatest potential for finding lung cancer at its earliest, most treatable phase, as well as extending and improving lives for lung cancer survivors.
LUNGevity is the only lung cancer organization with programmatic focuses on early detection and Career Development Awards. LUNGevity-funded researchers are working on finding a better way to detect lung cancer, and to better diagnose, treat, and prevent its recurrence. The research program is a crucial factor in moving the science forward to improve outcomes for people living with lung cancer.
Dr. Garon is the Director of the Thoracic Oncology Program at the Jonsson Comprehensive Cancer Center at UCLA and Associate Professor of Medicine in the Division of Hematology-Oncology at David Geffen School of Medicine at UCLA. He has been the principal investigator of peer-reviewed grants from various funding organizations, including the National Cancer Institute. His focus is on clinical research and biomarker development. He has served as the principal investigator on national and international phase I, II, and III clinical trials. Among these are trials that have led to the approval of drugs for the treatment of non-small cell lung cancer, including ramucirumab (Cyramza®) and the immunotherapy pembrolizumab (Keytruda®).
“We are honored that Dr. Garon has joined our Scientific Advisory Board,” said Andrea Ferris, President and Chairman of LUNGevity Foundation. “His expertise and advice will be invaluable to furthering LUNGevity’s goal to improve outcomes for lung cancer patients.”
Click here to read the complete press release on LUNGevity.org.
-
Hi, Lydia,
I'll see if I can find someone who can share more information about Tagrisso from personal experience. In the meantime, this webpage details some of the possible side effects of EGFR inhibitors https://www.lungevity.org/about-lung-cancer/lung-cancer-101/treatment-options/targeted-therapy
Please let us know if you have any other questions!
Lauren
--
Digital Community Manager
LUNGevity Foundation -
LUNGEVITY FOUNDATION INTRODUCES A NEW MOBILE APP TO HELP PATIENTS UNDERSTAND AND MANAGE LIFE WITH LUNG CANCER
Lung Cancer Navigator is a Customized Communication Hub that Puts Education, Care Management and Personal Support in the Palm of Your Hand
PR Newswire, WASHINGTON, DC (January 11, 2017)
Click here to view the multimedia press release.
LUNGevity, the nation’s leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably more manageable. The new Lung Cancer Navigator mobile app provides lung cancer patients with access to the latest medical and treatment information related to their specific lung cancer diagnosis, and serves as a convenient hub for organizing customized care and support networks, asking questions, describing and tracking symptoms, and managing multiple medications.
Lung cancer is the second most commonly diagnosed cancer worldwide, with more than 1.8 million new cases diagnosed each year. The LUNGevity Lung Cancer Navigator app provides tools and forums to help those coping with the disease (including caregivers and support network members) communicate important details in real time, while handling care management needs with efficiency, medical guidance and less stress.
“When someone receives a lung cancer diagnosis, it can be overwhelming,” said Andrea Ferris, President of LUNGevity Foundation. “Our goal with the LUNGevity Lung Cancer Navigator app is to empower patients and provide them with a forum for connecting to customized information and a support community that helps them navigate life with understanding and much less fear.”
While lung cancer can affect anyone regardless of gender or ethnicity, only 18% of people diagnosed with the disease survive five years or more. LUNGevity Foundation strives to change outcomes for people living with lung cancer through research, education, support and advocacy. Through the LUNGevity Lung Cancer Navigator app, LUNGevity Foundation aims to provide patients and caregivers with a greater sense of empowerment, understanding and improved management of personal diagnostic, treatment and appointment information. The LUNGevity Lung Cancer Navigator was developed through an educational grant from Bristol-Myers Squibb.
LUNGevity’s Lung Cancer Navigator Mobile App is available as a free download on iOS and Android devices. For more information and to view a demonstration video, visit https://www.lungevity.org/.
About Lung Cancer:
1 in 15 Americans will be diagnosed with lung cancer in their lifetime
More than 224,000 people in the U.S. will be diagnosed with lung cancer this year
About 60% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
Lung cancer kills more people than the next three cancers (colorectal, breast, and pancreatic) combined
Only 18% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it's caught before it spreads, the chance for 5-year survival improves dramatically
About LUNGevity Foundation:
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, please visit www.LUNGevity.org.###
Press Contact:
Cynthia Inácio
212-561-7476
cynthia.inacio@kingcompr.com
-
Hi, Robin,
Welcome to LCSC! We're glad you've joined as well. This is a great forum to connect with other patients/survivors who are living with a lung cancer diagnosis. I'm happy to hear that your side effects have been minimal. Please keep us posted on your CT scan results--we'll be sending lots of positive thoughts your way! Please feel free to explore the discussion boards and blogs and join in some of the conversations. And let us know if you have any specific questions or if you're looking for any additional resources/support.
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hi, BobbieA,
Welcome (back) to LCSC! I hope that you make many meaningful connections with other patients/survivors, caregivers, and advocates in this online community. Please feel free to explore the discussion boards and blogs and join in on any conversations that resonate with you. This is a great place to ask questions and get answers from patients/survivors with similar experience. And please let us know if there are any specific resources or support that you need and we'll be happy to help!
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hi, Stephanie,
Welcome to LCSC. My name is Lauren and I am the Digital Community Manager for LUNGevity. I'm glad that you've joined this community and hope that you can make many meaningful connections with other caregivers and survivors. I'll encourage our members who have experience with Keytruda to respond to your post. In the meantime, please feel free to explore the discussion boards and blogs. Everyone LCSC member's story is different, but this is a great place to find inspiration and hope!
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hello, Gage and JayJay,
Welcome to LCSC! I am glad to see that you've already connected with Tom. I hope that you will many meaningful connections with other patients/survivors, caregivers, and advocates whose lives have been affected by lung cancer through LCSC.
As the Digital Community Manager for LUNGevity Foundation, I am happy to help you find the resources and support that will be most helpful to you. Please feel free to continue exploring the message boards and joining the conversations which ressonnate with you. And please let me know if you'd like more information on any particular topic or about LUNGevity's Support & Survivorship programs.
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hi, Stephanie,
Welcome to LCSC! I am happy that you've already connected with some of our most active members. This is a great forum to ask questions and share experiences. Here is a link to LUNGevity's Lung Cancer 101 website, which provides comprehensive information about types of lung cancer and treatment options: https://www.lungevity.org/about-lung-cancer/lung-cancer-101/types-of-lung-cancer/lung-adenocarcinoma. Please keep us posted on your dad's MRI results.
Happy New Year!
With gratitude,
Lauren
--
Lauren Humphries
Digital Community Manager
LUNGevity Foundation -
On 12/19/2016 at 2:22 PM, Wendy Fought said:
Hi I am new to the group also was diagnosed with small cell lung cancer last week. Still in the unknown my MRI came back clear that is good as my cancer tends to spread to the brain its an aggressive cancer the way it is staged is limited or extensive. There is no stage 1,2,3,or 4. right now it is limited but the PET scan this morning will make the final determination. Hoping it has not spread. pretty scarred.
Wendy
Hi, Wendy,
I'm glad you've joined LCSC. This is a great place to connect with other survivors, patients, caregivers, and advocates and to ask questions. Once you have more information about your diagnosis, please feel free to share it with the group along with questions/concerns. We are here for you!
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hi, Yyg,
My name is Lauren and I am the Digital Community Manager for LUNGevity. I'm glad you've already connected with some of our members. This community is made up of patients, survivors, caregivers, and advocates who have all been affected by lung cancer, so it's a great place to ask questions.
Please let me know if there is any specific support or resources that you need. We offer peer-to-peer support programs for survivors and caregivers and we have survivorship conferences all over the country that feature education sessions, the latest information in research and treatment, and the opportunity to meet other survivors and caregivers in person. Here is a photo of the survivors under the age 50 at National HOPE Summit in Arlington, VA, last May (pictured with Chris Draft, bottom row-center):
-
That's wonderful news St. Michael! I am very happy for you and your family! Wishing all of you good health, hope, happiness, and healing in the new year!
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hi, Lydia,
Welcome to LCSC! I am sorry to hear about your diagnosis, but I'm glad that you've joined this online support community. This is a great place to connect with people like Donna, who can share experience, advice, and encouragement. Please feel free to join in conversations or start your own topics in the discussion boards. There are also member blogs, photo galleries, and a calendar of lung cancer events.
Here is a page on LUNGevity's website with tips for managing side effects: https://www.lungevity.org/support-survivorship/survivor-resource-center/living-well-with-lung-cancer/managing-treatment-side. I'd also suggest making a post to ask specific questions about side effects that are affecting you. Many of our members may have experienced similar side effects and can share what strategies worked best for them.
Please let me know if there are any specific resources/support that you need and I will be happy to help!
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hi, Michelle,
Welcome to LCSC! I am glad that you found us and I look forward to getting to know you. I work for LUNGevity as the Digital Community Manager. I became involved with the organization as a volunteer in 2011 when my uncle was diagnosed with Stage IV NSCLC. We just celebrated five years of survival with him this past fall. Like you and Susan, he has a positive attitude and is grateful for each new day.
I hope that you make many meaningful connections on this forum. Please feel free to explore the discussion boards and join in on any conversations that resonate with you. This is a great place to ask questions and our members are happy to share their experiences and (non-medical) advice. There are also community blogs, photo galleries, and a calendar with lung cancer events.
Please let me know if you are looking for any types of specific support or resources and I will be glad to help.
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Here is the link to the video on LUNGevity's YouTube page:
If you'd like to watch other stories from survivors, caregivers, advocates, and medical professionals, check out all of LUNGevity's videos: https://www.youtube.com/user/LUNGevityFoundation/videos
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Hello,
I'm very sorry to hear about your mom's diagnosis, but I'm happy that you've joined LCSC. I'm especially glad you've already connected with Tom. He is an incredible mentor to this community and can offer lots of reasons to have hope. I work for LUNGevity as the Digital Community Manager so I'm happy to talk with you about the support resources and programs we offer.
If you're interested in peer-to-peer support, LUNGevity offers a free LifeLine Support Partner program that matches patient-to-patient or caregiver-to-caregiver. LifeLine Support Partners are volunteers whose lives have also been impacted by lung cancer, and they can offer advice, experience, and understanding. Here is the link to LifeLine: https://www.lungevity.org/support-survivorship/get-connected/lungevity-lifeline. Please let me know if you'd like additional information about LifeLine and I'll put you in touch with my colleague Nikole, who manages the program.
I became involved with LUNGevity as a volunteer event coordinator after my uncle was diagnosed with Stage IV lung cancer in 2011. My uncle underwent chemotherapy, radiation, and multiple surgeries to address brain mets. When he found out he had ALK, he started taking a targeted therapy drug which produced great results for almost four years. This spring, he switched to another targeted therapy drug and is doing well. In September, we celebrated five years of survival as a family. In the past five years, he's attended his oldest son's wedding, his youngest son's graduation from college, and the birth of his first three grandchildren.
I also wanted to share David Gobin's story. I met David and his wife Stephanie at my first Breathe Deep Baltimore in Camden Yards. They're a wonderful couple and I love spending time with them. This is a video that our partner SU2C produced about David's story:
The theme in Tom and David and my uncle's stories is that there is always a reason to have hope. Please keep us posted about how you and your mom are doing and feel free to explore and join in on any of the discussion threads in this community.
Lauren
--
Digital Community Manager
LUNGevity Foundation
lhumphries@lungevity.org -
Hi, Maltman,
Welcome to LCSC! Your post inspired an idea for a new discussion board. Every Friday, I will share a weekly "Clip Report" with news about LUNGevity and news about lung cancer. I'll start the thread in the Lung Cancer In The News forum under News/Advocacy. I'll post the first clip report this Friday, December 16. Here is the link to the post where I introduced the clip report:
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
Good afternoon, LCSC members!
Every Friday, I will start sharing a weekly clip report in this forum. I encourage you to reply to each thread to let us know what kind of news stories are most interesting/relevant to you.
I'll post the first weekly clip report this Friday, December 16!
With gratitude,
Lauren
--
Digital Community Manager
LUNGevity Foundation -
On 11/29/2016 at 8:30 PM, Meloni said:
Got the results of my first post-treatment CT today. No evidence of cancer. Yeah!
I think I amused my doctor because throughout this month I've been poking and prodding everything that's even a little bit sore. I circled all my spots with a Sharpie marker so they wouldn't be missed.
Oncologist: I'm pretty certain the cancer hasn't spread to your hang nail.
Anyway, I'm scheduled to follow-up with a CT scan in three months, and of course flush my port in-between, since he thinks I should keep it "indefinitely" until we decide otherwise.
Meloni
That's wonderful news, Meloni! I'm so happy to hear it!
Lauren
--
Digital Community Manager
LUNGevity Foundation
Hello from Portugal
in INTRODUCE YOURSELF!
Posted
Hello, stokedsurfer, and welcome to LCSC!
I am happy to hear that your mother's surgery went well. Please continue to share updates. I am also glad to see that you've already connected with Tom and Donna. This community is a great place to ask questions and share stories. Please let us know how we can help you navigate your mother's treatment. We have many resources available, including the Lung Cancer Navigator App and the Lung Cancer Helpline. I am happy to help you find the information and resources that you need.
With gratitude,
Lauren
--
Lauren Humphries
Digital Community Manager